0 followers
With access to a reservoir of unexploited intracellular cancer targets, CDR-Life is advancing a growing pipeline of highly tumor-selective immunotherapies.
Christian Leisner
Lonza
37 followers
Roche
279 followers
Tessera Therapeutics
2 followers
89bio
2 followers
Kyverna Therapeutics
7 followers
Queen Mary University
6 followers
Ventyx Biosciences
1 follower
Longeveron
1 follower
Astria Therapeutics
1 follower
ADARx Pharmaceuticals
3 followers
Rapport Therapeutics
1 follower
Explore companies